Carson Wealth (CWM LLC)
XBI icon

Carson Wealth (CWM LLC)’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.65M Buy
28,608
+4,116
+17% +$514K 0.01% 939
2025
Q4 		$2.99M Buy
24,492
+10,699
+78% +$1.23M 0.01% 992
2025
Q3 		$1.38M Buy
13,793
+614
+5% +$55.3K ﹤0.01% 1247
2025
Q2 		$1.09M Sell
13,179
-3,494
-21% -$279K ﹤0.01% 1204
2025
Q1 		$1.35M Buy
16,673
+3,616
+28% +$323K 0.01% 1001
2024
Q4 		$1.18M Buy
13,057
+2,818
+28% +$273K ﹤0.01% 1002
2024
Q3 		$1.01M Buy
10,239
+1,849
+22% +$182K ﹤0.01% 1023
2024
Q2 		$778K Buy
8,390
+866
+12% +$77.6K ﹤0.01% 1027
2024
Q1 		$714K Sell
7,524
-2,559
-25% -$237K ﹤0.01% 993
2023
Q4 		$900K Sell
10,083
-12,366
-55% -$918K ﹤0.01% 853
2023
Q3 		$1.64M Buy
22,449
+21,284
+1,827% +$1.7M 0.01% 593
2023
Q2 		$97K Sell
1,165
-48
-4% -$4.01K ﹤0.01% 1590
2023
Q1 		$92K Buy
1,213
+2
+0.2% +$166 ﹤0.01% 1539
2022
Q4 		$101K Sell
1,211
-2,392
-66% -$194K ﹤0.01% 1376
2022
Q3 		$286K Buy
3,603
+816
+29% +$68.8K ﹤0.01% 924
2022
Q2 		$207K Sell
2,787
-1,484
-35% -$111K ﹤0.01% 1037
2022
Q1 		$384K Sell
4,271
-425
-9% -$39.2K ﹤0.01% 802
2021
Q4 		$526K Buy
+4,696
New +$566K ﹤0.01% 713
2021
Q2 		$597K Hold
4,408
– – ﹤0.01% 646
2021
Q1 		$597K Hold
4,408
– – ﹤0.01% 646
2020
Q4 		$597K Hold
4,408
– – ﹤0.01% 646
2020
Q3 		$597K Hold
4,408
– – ﹤0.01% 646
2020
Q2 		$597K Hold
4,408
– – ﹤0.01% 646
2020
Q1 		$597K Hold
4,408
– – ﹤0.01% 646
2019
Q4 		$597K Hold
4,408
– – ﹤0.01% 646
2019
Q3 		$597K Hold
4,408
– – ﹤0.01% 646
2019
Q2 		$597K Hold
4,408
– – ﹤0.01% 646
2019
Q1 		$597K Sell
4,408
-4,428
-50% -$377K ﹤0.01% 646
2018
Q4 		$634K Buy
8,836
+8,575
+3,285% +$691K 0.02% 421
2018
Q3 		$25K Buy
+261
New +$25.3K ﹤0.01% 908

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Carson Wealth (CWM LLC)'s XBI Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its State Street SPDR S&P Biotech ETF (XBI) stake by 17% in Q1 2026, buying an estimated $514K and bringing the position to 28,608 shares worth $3.65M. The position accounts for 0.01% of the portfolio, ranked #939.

Carson Wealth (CWM LLC) first reported a position in XBI in Q3 2018 and has held it in 30 quarters since. 815 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Carson Wealth (CWM LLC) held 28,608 shares of State Street SPDR S&P Biotech ETF worth $3.65M as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 4,116 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $514K.
  • State Street SPDR S&P Biotech ETF made up 0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #939 holding.
  • Carson Wealth (CWM LLC) first reported a position in State Street SPDR S&P Biotech ETF in Q3 2018 and has held it in 30 quarters since.
  • 815 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.